Patent ID: 6900189

Claim:
An oral dosage form for treatment of the symptoms of pain comprising a glucosamine material and a therapeutic amount of an analgesic compound, wherein the weight ratio of glucosamine material to analgesic compound is such that the analgesic efficacy of the oral dosage form in alleviating the symptoms of pain when administered orally is greater than the analgesic efficacy of the analgesic compound alone at the dosage level for the analgesic compound, the glucosamine material is selected from the group consisting of α- or β-glucosamine or mixtures thereof, N-acetyl glucosamine, glucosamine sulfate, and glucosamine hydrochloride, the analgesic compound is ibuprofen or ketoprofen, and the weight ratio of glucosamine material to said analgesic compound is about 2:1 or more, said ratio being calculated based on glucosamine sulfate as the glucosamine material.